Canada markets closed

I-Mab (IMAB)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.7600-0.0050 (-0.28%)
At close: 04:00PM EDT
1.7600 0.00 (0.00%)
After hours: 04:05PM EDT
Full screen
Loading interactive chart...
  • Thomson Reuters StreetEvents

    Q1 2024 Summit Therapeutics Inc Earnings Call

    Q1 2024 Summit Therapeutics Inc Earnings Call

  • PR Newswire

    I-MAB Filed 2023 Annual Report on Form 20-F

    I-Mab (the "Company") (NASDAQ: IMAB), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, today announced that it has filed its annual report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission ("SEC") on April 30, 2024.

  • PR Newswire

    I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference

    I-Mab (NASDAQ: IMAB), a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, today announced that management will present at the 23rd Annual Needham Virtual Healthcare Conference on April 11, 2024.